{"id":"W2977743112","doi":"10.1016/j.euo.2019.09.002","title":"First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis","year":2019,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Axitinib; Medicine; Oncology; Internal medicine; Renal cell carcinoma; Population; Clinical endpoint; Pembrolizumab; Adverse effect; Progression-free survival; Clinical trial; Meta-analysis; Atezolizumab; Avelumab; Cancer; Overall survival; Immunotherapy; Sunitinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001611911,0.001227119,0.0275416,0.0006291955,0.00007773948,0.0000096669,0.0003480895,0.0002925613,0.0005372976],"category_scores_gemma":[0.0001356124,0.0007177708,0.006033465,0.0009693559,0.0002786801,0.00002696704,0.0002083121,0.0004362088,0.0004853014],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004334406,"about_ca_system_score_gemma":0.0004450581,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002807135,"about_ca_topic_score_gemma":0.00002989147,"domain_scores_codex":[0.9881252,0.006593545,0.003023721,0.001274123,0.0002992707,0.0006841325],"domain_scores_gemma":[0.9927244,0.001982938,0.002810089,0.001964845,0.0001824505,0.0003353461],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00005221952,0.000810964,0.00001115431,0.7631314,0.2302357,0.002919322,0.00006564592,0.0000409784,1.273296e-7,0.00001966259,0.0004312756,0.002281492],"study_design_scores_gemma":[0.0009635027,0.00749733,0.00001483571,0.002951937,0.7591463,0.001587154,0.000002504763,0.000008670817,2.595467e-7,0.000002740927,0.2275385,0.0002863174],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001333915,0.9872023,0.00005832588,0.0003045609,0.0001114803,0.007257371,0.000108351,0.00003991737,0.004904377],"genre_scores_gemma":[0.0007098474,0.9923201,0.0007528664,0.0006793602,0.0001232404,0.0006248825,0.0004892726,0.0001610197,0.004139452],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7601795,"threshold_uncertainty_score":0.9995273,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1707180087076591,"score_gpt":0.3583626597912709,"score_spread":0.1876446510836118,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}